Evaluation of a spot-on imidacloprid-moxidectin formulation (Advocate®) for the treatment of naturally occurring esophageal spirocercosis in dogs: a double-blinded, placebo-controlled study

BACKGROUND: Dogs are the definitive hosts of Spirocerca lupi. Spirocercosis is treated by prolonged avermectin administration by injection or daily oral doses. In this prospective, double-blinded, placebo-controlled, clinical trial, the efficacy of imidacloprid and moxidectin spot-on formulation (Ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Segev, Gilad, Rojas, Alicia, Lavy, Eran, Yaffe, Marganit, Aroch, Itamar, Baneth, Gad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838953/
https://www.ncbi.nlm.nih.gov/pubmed/29506575
http://dx.doi.org/10.1186/s13071-018-2731-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838953/
https://www.ncbi.nlm.nih.gov/pubmed/29506575
http://dx.doi.org/10.1186/s13071-018-2731-x

Ejemplares similares